Norrie
Norrie disease is a rare genetic disorder that primarily affects the eyes and leads to blindness. It is named after the Scottish ophthalmologist Gordon Norrie, who first described the condition in 1927. The disease is caused by mutations in the NDP gene and is inherited in an X-linked recessive pattern.
Symptoms[edit]
The most common symptom of Norrie disease is blindness or severe visual impairment at birth or early infancy. This is caused by an abnormal development of the retina, known as Leber's congenital amaurosis or persistent hyperplastic primary vitreous (PHPV). Other symptoms can include hearing loss, intellectual disability, and behavioral problems.
Causes[edit]
Norrie disease is caused by mutations in the NDP gene, which provides instructions for making a protein called norrin. This protein plays a crucial role in the development of the eye and other parts of the body. Mutations in the NDP gene disrupt the function of norrin, leading to the symptoms of Norrie disease.
Diagnosis[edit]
The diagnosis of Norrie disease is based on the clinical symptoms, family history, and genetic testing. Genetic testing can confirm the diagnosis by identifying a mutation in the NDP gene.
Treatment[edit]
There is currently no cure for Norrie disease. Treatment is supportive and aims to improve the quality of life for individuals with the condition. This can include educational support for those with intellectual disabilities, hearing aids for those with hearing loss, and behavioral therapy for those with behavioral problems.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
